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Morphological and physiological studies have shown that
various nephron segments are different functionally and meta-
bolically. Major advances to understand renal metabolism have
required improved techniques to study the problem of tissue
heterogeneity in the kidney. The degree of heterogeneity within
the kidney in renal disease may increase because pathological
processes are many times focal or they produce histological
changes in certain areas and adaptive changes in other zones of
the kidney. Hence, methodological problems have hampered
the studies of renal metabolism, particularly at the nephron
level, in kidney diseases. Most metabolic studies have been
done in experimental animal models of renal disease. This
article provides an overview of changes in renal metabolism
that occur in urinary tract obstruction, nephrotoxic or ischemic-
induced acute renal failure, and in chronic models of reduced
renal mass. The information available is limited and the exist-
ence of major gaps in our understanding of renal metabolism in
diseases of the kidney is evident.
Urinary tract obstruction
Urinary tract obstruction is associated with several alter-
ations of renal metabolism [II, including changes in: (I) sub-
strate metabolism and oxygen consumption, (2) the activity of
several enzymes, (3) the response to hormones or production of
hormones by the kidney and (4) lipid metabolism and compo-
sition of the obstructed kidney.
Oxygen conswnption and substrate metabolism
Oxygen consumption by the kidney is related stoichio-
metrically to sodium reabsorption. Because absolute sodium
reabsorption, in turn, depends on the filtered load of sodium, 02
consumption also relates directly to the levels of glomerular
filtration rate and renal blood flow. It is known that urinary tract
obstruction results in an immediate decrease in GFR and a
progressive fall in renal blood flow after 4 to 5 hr of obstruction
[2]. Hence, the filtered load of sodium decreases and diminished
02 consumption by the kidney is expected. Measurements in
vivo during obstruction have revealed a decrease in 02 con-
sumption of approximately 60% with a concomitant fall in CO2
production after 3 hr of ureteral obstruction [3, 41. The ratio of
CO2 production to 02 consumption, the respiratory quotient(RQ), increased significantly, possibly due to increased
anaerobic glycolysis or to the presence of anaerobic decar-
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boxylation in the kidney. In vitro data using renal cortical slices
have also demonstrated a reduction in 02 consumption with an
increase in anaerobic glycolysis [5—8], Oxygen consumption
was reduced markedly in renal cortical slices from obstructed
kidneys but was not diminished significantly in the renal me-
dulla. On the other hand, there was an increase in the anaerobic
glycolysis of the renal cortex. Indeed, values for anaerobic
glycolysis may increase as much as tenfold normal with pro-
longed obstruction of approximately 2 weeks [41. Even after
release of obstruction lasting 2 weeks, low 02 consumption and
high rates of anaerobic glycolysis persist, suggesting an irre-
versible type of damage to the kidney after prolonged obstruc-
tion [9].
Electron microscopic examination of the obstructed kidney
has demonstrated significant morphological changes in
mitochondria, particularly of the proximal tubule. These
subcellular elements show swelling, distorted cristae, and oc-
casional vacuolation after 24 hr of ureteral obstruction [8]. The
decrease in 02 consumption is accompanied by a fall in the renal
uptake of certain substrates, particularly lactate [101. The
mechanisms responsible for the fall in RQ and the increase in
anaerobic glycolysis are unknown. The fall in 02 consumption
may be secondary to decreased active reabsorption of sodium
and other solutes [10]. Such events, therefore, may reflect
metabolic alterations in the proximal tubule where the bulk of
the filtered sodium is reabsorbed. The increased anaerobic
glycolysis may be due to changes in the metabolism of renal
tubular cells and/or the appearance of new more undifferenti-
ated cell types capable of utilizing glucose anaerobically. A
morphological study of obstructed kidneys by Nagle et al [11]
and Nagle, Johnson, and Jervis [12] revealed enlargement of the
cortical interstitial space after I day of obstruction. The inter-
stitial space contained three main cell types: (I) altered inter-
stitial fibroblasts; (2) occasional mononuclear cells; and (3)
extravasated red blood cells. Metabolism of these cells may
account, at least in part, for the significant increase observed in
anaerobic glycolysis during obstruction.
Evaluation of metabolic parameters in cortical slices obtained
from the control and post-obstructed kidneys of rats subjected
to 24 hr of complete unilateral ureteral obstruction revealed that
02 consumption, glutamine uptake, and glutamine oxidation
were considerably lower in the experimental kidney than in the
normal contralateral kidney [8]. In addition, the decarboxyla-
tion of x-ketoglutarate has been found to be decreased [131.
Renal gluconeogenesis. The kidney shares with the liver the
ability to produce glucose from noncarbohydrate precursors.
Enzymatic analysis of single nephron segments revealed that
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the key limiting enzyme of gluconeogenesis, phosphoenol-
pyruvate carboxykinase, is located mainly in the proximal
tubule [14]. In addition, studies of gluconeogenesis in microdis-
sected single segments confirmed that the ability to produce
glucose was confined to the convoluted portion and pars recta
of the proximal tubule [15]. Renal gluconeogenesis in the
obstructed kidney is reduced, by approximately 40%, after 24
hr of ureteral ligation but not after 6 hr of obstruction [8, 13].
Use of isolated proximal tubules obtained from obstructed
kidneys revealed that the rates of glucose production from
a-ketoglutarate, malate, and pyruvate were 20 to 40% lower
than the rates of the contralateral control kidney [13]. However,
glucose production from glycerol, a substrate that enters the
gluconeogenic pathway above the level of phosphoenolpyru-
vate, was suppressed by only 7% of that in the contralateral
control kidney. In addition, measurements of key intermediates
of the gluconeogenic pathway showed a crossover between
oxaloacetate and phosphoenolpyruvate. These data suggest an
inhibition of phosphoenolpyruvate carboxykinase (PEPCK) ac-
tivity in the obstructed kidney as the cause of the decrease in
gluconeogenesis. It has been shown that certain ions (hydrogen,
calcium) and hormones (parathyroid hormone) may regulate
renal gluconeogenesis by affecting PEPCK activity, but the
mechanisms underlying the decreased activity of PEPCK in the
obstructed kidney are unknown.
Renal ammonia genesis. A marked decrease in acid excretion
has been observed after relief of unilateral ureteral obstruction
[21. In the initial few hours after release of obstruction there is
a marked decrease in titratable acid excretion presumably due
to both a decrement in the urinary excretion of phosphate and
inability to lower urine pH to the range necessary for optimal
generation of titratable acid [2]. In addition, ammonia excretion
is decreased. This latter defect may be related to decreased flux
of ammonia from epithelial cells into the urine due to an
increase in urinary pH or to defective recycling of ammonia
from the loop of Henle to the cortical collecting duct [161.
However, studies in vitro have demonstrated decreased capac-
ity to produce ammonia from glutamine by cortical slices
obtained from post-obstructed kidneys when compared to slices
obtained from the contralateral control kidney [8]. This de-
crease in ammonia production was accompanied by a decrease
in glutamine uptake and oxidation. It is of interest that 60 days
after the release of unilateral obstruction in the rat when urine
pH and titratable acid excretion are normal, the defect in
ammonia excretion is still present [17]. This decrease in ammo-
nia excretion may relate to a permanent loss of functioning
nephrons [17]. Other mechanisms responsible for decreased
ammonia generation have not been investigated. For example,
no data are available concerning the activities of ammoniagenic
enzymes in the post-obstructed kidney.
Levels of adenine nucleotides. A marked decrease in adenine
nucleotides levels occurs after 24 hr of ureteral obstruction [8,
13]. ATP levels may decrease to 50 to 70% of normal values,
and there is a concomitant fall in ADP and AMP levels [13].
These changes in adenine nucleotide levels may be due to
mitochondrial damage and decreased oxidative capacity of the
post-obstructed kidney. ATP values have been reported to
return close to normal 2 hr after release of obstruction lasting 24
and 48 hr [13]. However, this observation has not been con-
firmed by others, to our knowledge [8]. Of note is that the
Table 1. Changes in renal metabolism in urinary tract obstruction
(1) Energy and substrate metabolism
Decreased 02 consumption
Decreased oxidation of substrates (glutamine, glucose, oleic
acid)
Decreased substrate uptake
Decreased levels of adenine nucleotides
Decreased ammoniagenesis
Decreased gluconeogenesis
Increased anaerobic glycolysis
Increased synthesis of triglycerides
(2) Activity of enzymes
Decreased Increased
Alkaline phosphatase
NaK ATPase
Glucose-6-phosphatase
Phosphoenolpyruvate carboxy-
kinase (PEPCK)
Succinic dehydrogenase
NADH and NADPH dehydrog-
enase
a-glycerophosphate dehydrog-
enase
LDH 1,2,3 isoenzymes
(3) Hormonal responses
Decreased generation of cyclic AMP and phosphaturia after
PTH administration
Decreased water flow and hydraulic permeability of the corti-
cal collecting duct in response to antidiuretic hormone or
cyclic AMP
Decreased transcellular voltage of the cortical collecting duct
after exposure to mineralocorticoids
Increased synthesis of prostaglandins after exposure to anglo-
tensin II or bradykinin
Increased renin secretion
Increased erythropoietin secretion
(4) Lipid abnormalities
functional derangements persist at 2 hr after the release of
obstruction even when the recovery of ATP levels is complete.
Activity of enzymes
Urinary tract obstruction is associated with alterations in the
activity of several enzymes (Table 1). There is a 60 to 70%
reduction in the activity of alkaline phosphatase in the convo-
luted tubule and pars recta of the proximal tubule after 2 days of
unilateral ureteral obstruction in the rat [18]. Prolonged
obstruction for 7 days further decreased the activity of the
enzyme in the pars recta but not in the proximal convoluted
tubule when compared to the levels determined after 2 days of
obstruction. The reduced alkaline phosphatase activity was still
present 2 days after release of unilateral ureteral obstruction of
48 hours duration. By 6 days after relief of obstruction, how-
ever, the enzyme activity had returned to normal levels. No
changes in the activity of acid phosphatase was observed in
Glucose phsophate dehydrog-
enase
6-phosphogluconic dehydrog-
enase
LDH 4,5 isoenzymes
Phospholipase C
Cyclooxygenase
Accumulation of triglycerides (both cortex and medulla)
Decrease in phospholipid content (cortex)
Increased synthesis of prostaglandins
Decreased oxidation of fatty acids
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either the pars recta or convoluted portion of the proximal
tubule up to 7 days of unilateral ureteral obstruction. However,
acid phosphatase activity increased significantly early after
release of obstruction but returned to control levels by 6 days.
Since the brush border of proximal tubules is rich in alkaline
phosphatase and since there is a marked decrease in the
brushborder membranes of proximal tubules in the obstructed
kidney, the reduction in the activity of alkaline phosphatase
may reflect loss of brushborder membranes rather than specific
inactivation of the enzyme during obstruction. Histological
observations seem to indicate, however, that the reduction in
alkaline phosphatase activity in proximal nephron segments is
out of proportion to the loss of the brushborder membrane [18].
Moreover, the morphology of the brush border appears little
changed from normal 2 days after the release of obstruction
lasting 48 hours when activity of alkaline phosphatase is still
decreased. It is possible that synthesis and incorporation of the
new enzyme into the brushborder membranes may lag behind
the gross histological normalization of the brushborder mem-
branes after release of obstruction. Such a postulate may
explain the reduced activity of alkaline phosphatase in the
brush border in the presence of a membrane of normal histo-
logical appearance. Another potential explanation for the de-
crease in alkaline phosphatase is that its loss is selective. In
support of this postulate is the recent finding of Weinreb et a!
[191 who found a decrease in alkaline phosphatase in the
experimental kidney of dogs after 24 hr of unilateral ureteral
obstruction. By contrast, the activity of maltase, another en-
zyme located in the brush border, was unchanged.
Microenzyme assays of dissected nephron segments have
shown that the activities of glucose-6-phosphate dehydrogenase
and 6-phosphogluconic dehydrogenase, both enzymes of the
pentose shunt pathway, were increased in the obstructed kid-
ney [20]. The activity of glucose-6-phosphate dehydrogenase
remained elevated 2 days after release of obstruction but
returned toward normal values 6 days after the release of
obstruction lasting 48 hr. It should be noted that in these studies
enzyme activities were only examined in proximal nephron
segments, and it should be remembered that glucose-6-phos-
phate dehydrogenase is also present in the thick ascending limb
of Henle and distal convoluted tubule with an activity compa-
rable to that in proximal tubules [111. Histochemical studies by
Nagle et a! [11] showed that the activity of this enzyme of the
pentose shunt pathway was unaffected in these nephron seg-
ments of the rabbit kidney after 1 or 4 days of unilateral ureteral
obstruction. Glucose is oxidized to a small extent in the
proximal convoluted tubules but significant glucose oxidation
occurs in the thick ascending limb of Henle where approxi-
mately one-half of the glucose oxidized is metabolized through
the pentose shunt pathway [21]. The biologic and physiologic
role of this pathway in the renal tubule is not well understood.
It has been suggested that at least a portion of sodium transport
and/or hydrogen secretion by the kidney may be regulated by
the activity of the pentose shunt pathway [22].
Unilateral ureteral ligation decreases the activity of sodium-
potassium adenosine triphosphatase (Na-K ATPase) in the
experimental kidney [23]. Magnesium ATPase and Na-K
ATPase activities have been measured in microsomal fractions
prepared from hydronephrotic and contralateral normal kidneys
of rats at 1, 2, and 5 days after unilateral ureteral ligation. No
changes in magnesium ATPase were observed. On the other
hand, there was a steady decrease in Na-K ATPase with longer
periods of obstruction. It has also been reported that Na-K
ATPase is not decreased after 24 hr of ureteral obstruction in
the rat [241. After release, however, there was a decrease in the
activity of the enzyme which persisted even 7 days after relief
of the obstruction.
The mechanisms underlying the decrease of Na-K ATPase
activity during obstruction are not yet known. The direct effect
of obstruction causing loss of functional nephrons and hence a
decrease in Na-K ATPase activity has been explored. Since
normal enzyme activity was observed after 24 hr of obstruction
while Na-K ATPase was inhibited in the post-obstructed kidney
with recovery of renal function, this possibility seems unlikely
[251. It also has been suggested that the decreased solute
concentration in the medulla of the post-obstructed kidney may
influence the activity of Na-K ATPase [26]. It is well known
that high osmolality of the incubation medium stimulates the
activity of this enzyme in the outer medulla [27] and that
medullary tonicity is reduced markedly in the obstructed kid-
ney. Incubation of slices from the outer medulla in a medium
made hypertonic by the addition of NaC1 was found to stimulate
Na-K ATPase activity equally in the obstructed and the con-
tralateral control kidney [26], suggesting that the decrease in
Na-K ATPase of the outer medulla of the obstructed kidney
may be related to reduced medullary solute concentration.
Stimulation of Na-K ATPase in medullary slices and slices
obtained from the outer medulla of the obstructed kidney could
be enhanced by adding high concentrations of choline chloride
or sucrose to the incubation medium. From these observations,
it was proposed that Na-K ATPase activity in the obstructed
kidney may be unusually sensitive to high interstitial tonicity
regardless of the solute involved. It is not known whether the
reduced Na-K ATPase activity of the proximal nephron plays a
role in the altered transport of sodium and potassium seen in
obstructive nephropathy.
Hormonal responses
Parathyroid hormone. A decreased phosphaturic response of
the experimental kidney to the infusion of PTH has been
reported in animals and humans after release of unilateral
ureteral obstruction [28—30]. Schlondorff et al [31] described
that basal adenylate cyclase activity in kidney cortex doubled
after 3 to 7 days of obstruction in rats but the response to NaF
and parathyroid hormone was decreased. Similarly, in vivo
infusion of parathyroid hormone resulted in lower cyclic AMP
levels in the obstructed kidney cortex. Parathyroidectomy or
pretreatment with beta-adrenergic blockers had no effect. Inhi-
bition of prostaglandins by indomethacin administration de-
creased but did not abolish the differences between the control
and obstructed kidneys. Stokes, Martin, and Klahr [32] recently
examined the initial events in the action of parathyroid hor-
mone, namely, receptor binding and adenylate cyclase activa-
tion in post-obstructed canine kidneys. Basolateral membranes
were prepared from both the post-obstructed and contralateral
control kidneys of dogs. Maximal activation of adenylate cy-
clase by PTH was 35% lower in basolateral membranes from
the experimental kidney as compared to the control. Addition
of GTP failed to correct the decreased enzyme activity in
response to PTH. Sodium fluoride activation, a measure of the
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interaction of the nucleotide regulatory component with the
catalytic unit of the adenylate cyclase, was similar in basolat-
era! membranes from post-obstructed and control kidneys.
Similarly, activation of the catalytic unit of the enzyme by
manganese was not different. On the other hand, the specific
binding of iodine-labeled synthetic PTH 1-34 was reduced
markedly in basolateral membranes from the post-obstructed
kidney as compared to the control. This decrease in binding
occurred without change in hormone affinity for the binding
site. These data suggest there is decreased activation of ade-
nylate cyclase by PTH presumably as a consequence of appar-
ent loss of receptors for the hormone in the basolateral mem-
branes of renal tubular cells of post-obstructed kidneys. The
mechanisms responsible for this apparent loss of receptors are
not immediately apparent.
Antidiuretic hormone and cyclic AMP. Ureteral obstruction
of 4 or 24 hr in the rabbit decreases the hydro-osmotic response
to ADH of isolated perfused cortical collecting ducts obtained
from the obstructed kidney [33, 34]. This nephron segment also
showed a decreased hydro-osmotic response to cyclic AMP.
Administration of indomethacin to the rabbits to inhibit
prostaglandin synthesis in vivo did not restore the decreased
hydro-osmotic response to ADH of the cortical collecting duct
obtained from obstructed kidneys [341. Pretreatment with
mineralocorticoids, a maneuver which enhances the effects of
ADH on hydraulic water permeability, did not modify the
decreased response to the hormone seen in cortical collecting
ducts obtained from the obstructed kidney [34].
Mineralocorticoid hormones. Campbell, Klahr, and Bello-
Reuss [34] found a decreased transcellular voltage in cortical
collecting ducts prepared from the obstructed kidney of rabbits
subjected to unilateral ureteral obstruction as compared to
collecting ducts obtained from control kidneys of the same
animal or from sham-operated control animals. Administration
of mineralocorticoids in vivo markedly increases transcellular
voltage in cortical collecting ducts from normal rabbits presum-
ably by increasing sodium reabsorption. This response to
mineralocorticoids was abolished completely in cortical collect-
ing ducts obtained from obstructed kidneys. However, the
decreased transcellular voltage seen in cortical collecting ducts
obtained from the obstructed kidney could be restored toward
normal by pretreating the animals in vivo with indomethacin
prior to harvesting the kidneys. These data suggest that in-
creased endogenous production of prostaglandins, presumably
at the level of the cortical collecting duct, may inhibit sodium
reabsorption and hence decrease transcellular voltage in this
segment. The response to mineralocorticoids is abolished. The
mechanisms of this decreased response to mineralocorticoids is
not apparent. It may relate, as shown by the results of indo-
methacin administration, to the high levels of endogenous
prostaglandins in the obstructed kidney as compared to the
contralateral control kidney.
Prostaglandins, angiotensin II, and bradykinin. It has been
shown that the obstructed kidney has an increased basal
production of prostaglandins [35]. The increased synthesis of
prostaglandins by the obstructed kidney has been reviewed in
detail elsewhere [36]. Furthermore, in response to the
exogenous administration of angiotensin II or bradykinin, the
obstructed kidney responds with a greater output of prostaglan-
dins than the contralateral control kidney. Hence, there is an
increased sensitivity of the obstructed kidney to the actions of
bradykinin and angiotensin II. This response presumably re-
lates to increased activity of the enzymes which metabolize
arachidonic acid to prostanoids.
Renin. Generally, three intrarenal receptors control renin
secretion: the macula densa [37], the neurogenic receptor which
stimulates renin release by a beta-receptor and inhibits it by an
alpha-receptor [38—40], and the vascular stretch receptor
[41—42]. Obstruction of the ureter could increase renin release
by decreasing delivery of sodium and chloride to the distal
nephron (macula densa mechanisms) or by decreasing the
transmural pressure at the baroreceptor as a consequence of
dilatation of afferent arterioles. The stimulatory effect on renin
release of a rise in ureteral pressure exceeds the inhibitory
effect of increased sodium excretion following normal saline
infusion [43]. Also, maximum renin release coincides with
complete arteriolar dilatation. These observations suggest that
arteriolar dilatation is the predominant stimulus to renin secre-
tion during ureteral ligation. Since the vasodilatation that fol-
lows acute ureteral occlusion is at least partially mediated by
prostaglandins, it is possible that prostaglandins may directly
(or indirectly through the baroreceptor mechanism) serve as the
stimulus for renin release. Renin secretion after acute ureteral
obstruction is blocked by prior administration of indomethacin
[44]. However, since renal cortical prostaglandins, in particular
PGI2 [45] and 6-keto-PGE1 [46], are effective in releasing renin
from renal cortical slices, it is still debatable whether the
increased renin release is a direct effect of released prostaglan-
dins or an indirect effect via the vascular stretch receptor. Of
interest is the fact that changes in renin secretion seen with
acute ureteral obstruction have also been documented in the
MRC-H strain of rats with congenital hydronephrosis [47].
Erythropoietin
Absolute erythrocytosis has been described in several pa-
tients with solitary renal cysts, polycystic kidney, and hydro-
nephrosis [48, 49]. In some of these patients erythropoietin
assays on cyst fluid, serum, or urine have indicated the pres-
ence of erythropoietic material [50]. Since both cystic disease
and hydronephrosis may augment erythropoietin production,
the role of increased tissue pressure has been evaluated.
Subcapsular injection of plastic or ligation of the ureteral in
rabbits was associated with some degree of erythrocytosis [51]
though direct measurements of erythropoietin content were not
done.
Changes in tissue lipids and lipid metabolism
Muercke, Mandal, and Volini [52] first described the pres-
ence of lipid droplets in medullary interstitial cells. Nissen and
Bojesen [53] reported that these lipid droplets consisted mainly
of triglycerides, cholesterol esters, and free long-chain fatty
acids. They suggested that these materials were stored as
substrates for prostaglandin synthetase. They found abundant
quantities of arachidonic acid, the precursor of prostaglandins
in the renal medulla. Comai, Prose, and Farber [54] reported
that in these lipid droplets, triglycerides were unique because
they contained high percentages of linolenic, arachidonic, and
adrenic acids. It was observed that in rabbits after 48 and 72 hr
of ureteral obstruction, there was a marked increase in the
number of lipid droplets in the interstitial cells, a marked
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increase in the triglyceride:free fatty-acid ratio, and the
triglycerides were further enriched in linolenic and arachidonic
acids [551. On the other hand, the amount of polar lipids in these
droplets was small (approximately 1%) and did not change
significantly with ureteral obstruction. Since current dogma
suggests that the precursor pooi of arachidonic acid for
prostaglandin biosynthesis resides in phospholipids, the rela-
tion of the marked enrichment of triglycerides with linolenic
acid and arachidonic acid, precursors of prostaglandin synthe-
sis, to the alteration in the biosynthesis of these prostanoids in
obstruction is far from clear. Tannenbaum, Purkerson, and
Klahr [561 found that ureteral obstruction of 24 hr in the rat
resulted in an increase in triglycerides and a decrease in
phospholipid content of the kidney. There was increased incor-
poration of 14C-oleic or '4C-arachidonic acid into triglycerides
in both the cortex and medulla. In addition, there was a marked
decrease in fatty acid oxidation as indicated by decreased
formation of 14CO2 from '4C-oleic acid. The studies of Tan-
nenbaum, Purkerson, and Klahr [56] suggested that there was
an increase in the net synthetic rate of triglycerides in the
obstructed kidney. This increased synthesis of triglycerides
may be related to decreased fatty acid oxidation and increased
release of fatty acids from phospholipids perhaps due to in-
creased activity of phospholipase. More recent experiments
have analyzed the total phospholipid and cholesterol content of
basolateral membranes and brushborder membranes from ob-
structed and control kidneys in dogs with unilateral ureteral
obstruction. It was found that the total phospholipid content of
the obstructed kidney was decreased in basolateral membranes
but not in brushborder membranes. Most of the decrease in
total phospholipid content observed in basolateral membranes
could be attributed to a marked decrease in phosphatidylcholine
in the obstructed kidney. There was a small but significant
increase in the content of phosphatidylethanolamine in basolat-
eral membranes from the obstructed kidney, but no differences
were seen in phosphatidylserine. There was also a decrease in
the cholesterol content of basolateral membranes. The biolog-
ical significance of these alterations in the lipid composition of
the basolateral membrane is not immediately apparent. How-
ever, we would like to postulate that alterations in the lipid
composition of basolateral membranes may underlie some of
the changes in hormonal responsiveness observed in the kidney
of animals with urinary tract obstruction.
Acute rena/failure
Several published studies deal with metabolic alterations of
the nephron in acute renal failure, conducted mainly in exper-
imental animal models. Only the metabolic changes of two
models of acute renal failure will be discussed: Models of
ischemic renal failure produced either by the infusion of norep-
inephrine or occlusion of the renal artery and nephrotoxic
models, as exemplified by aminoglycoside or mercury chloride
administration. In these experimental models two phases of
cellular injury have been described, an early reversible phase in
which plasma membranes are intact and a late or irreversible
phase with loss of integrity of plasma membranes [57]. Specifi-
cally the proximal tubule is the major nephron segment
affected. The S3 segment is most susceptible to ischemia and
heavy metals and the Sl-S2 segments are affected in amino-
glycoside nephrotoxicity [58, 59]. It is of note that functional
and presumably metabolic tubular defects precede any evi-
dence of morphological injury [60, 61].
Levels of adenine nucleotides
The levels of adenine nucleotides have been determined in
kidneys of animals with ischemic-induced or nephrotoxin-
induced acute renal failure. There was a marked fall in ATP and
an initial increase in AMP levels 2 mm after onset of ischemia.
By 15 mm there was a decrease in ATP to 13% of control
values, of ADP levels to 42% of control. Total adenosine levels
fell to 72% of control and there was a persistent elevation in the
levels of AMP to about three times the levels observed in
control animals. However, by 90 mm there was a decrease in all
nucleotides (ATP, ADP, and AMP) with a total decrease in total
adenosine to about 80% of control values [62, 63]. In
nephrotoxic-mediated acute renal failure high energy phosphate
compounds are also decreased. With gentamicin-induced injury
the levels of ATP in the cortex fall. In mercury chloride-induced
acute renal failure, ATP levels are 80% of control 1 hr after
infusion of HgCl2, and the levels decreased further to 42% of
control 48 hr after the administration of the heavy metal [64].
Several studies indicate that infusion of exogenous nucleotides
may protect against progression of acute renal failure in several
experimental models, possibly by replacing ATP needed for cell
repair [65—67]. The largest decrease in ATP occurs during the
early or reversible phase of acute renal failure and recovery of
renal function may correlate inversely with depletion of the
nucleotide pool and duration of injury [571.
Mitochondrial function and morphology
With ischemic injury several morphological changes occur in
mitochondria. These include loss of intramitochondrial dense
granules, dilatation of spaces between mitochondrial cristae
and moderate swelling [68]. All of these changes are reversible.
With progression of ischemia there is further swelling, fragmen-
tation of the cristae and formation of dense bodies containing
calcium and phosphate. Mitochondrial function is altered at 15
mm after induction of ischemia. Gentamicin added to
mitochondria in vitro inhibits calcium transport into
mitochondria and stimulates Stage 4 respiration while inhibiting
Stage 3 respiration. Administration of gentamycin in vivo
results only in inhibition of Stage 3 respiration. The differences
observed between the in vivo and in vitro experiments may
relate to sequestration of the aminoglycoside gentamicin in
lysosomes of intact cells in the in vivo experiments. The
mitochondrial injury with aminoglycosides seems to be related
to their cationic properties and displacement of magnesium
from binding sites in the membrane [69, 70]. Alterations in
mitochondrial function have also been observed with mercury
chloride-induced acute renal failure. Thus, both ischemic and
nephrotoxic-induced acute renal failure decrease oxidative
phosphorylation in mitochondria.
Enzyme activities
The activity of several enzymes has been described in
nephrotoxic-induced acute renal failure. There is a decrease in
the activities of Na-K ATPase [71, 721, magnesium ATPase,
alkaline phosphatase, and y-glutamyltransferase [73]. Cortical
slices obtained from kidneys of animals with nephrotoxic-
induced acute renal failure have decreased transport and accu-
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Table 2. Role of prostaglandins in experimental models of acute renal failurea
Animal Norepinephrine Ischemia Glycerol
Mercuric
chloride
Obstructive
uropathy
Changes in prosta- Rat High urinary POE Low POE High POE High POE2
glandin synthesis
Rabbit
excretion
High POE
High TXA2
High POE
High TXB2
High POE2
High TXB2
Dog High venous PG
Effect of inhibition Rat Indo worsens Imidazole improves
of prostaglandin Indo blocks protective Indomethacin
synthesis
Rabbit Indo worsens
effect of saline
Indo worsens Indo—no
effect
blocks imidazole
Effect of "prosta- Rat Saline protects POE2 protects
glandin' '-infusion
Dog
Bradykinin protects
POE2 protects
PGE1 partially
protects
PG!2 protects
POE1 protects
a Modified with permission from [86].
Abbreviations: PG, prostaglandins; TX, thromboxanes.
mulation of para-aminohippurate (PAH) and decreased trans-
port of N-methylnicotinamide [74].
Lipid metabolism in acute renal failure
Phospholipids are major constituents of plasma membranes
and may participate in the regulation of membrane-bound
enzymes. With ischemia there is a decrease in phosphatidyl-
choline and phosphatidylethanolamine [75, 76]. There is also
increased incorporation of choline into membranes [77]. An
increase in free-fatty acids from the mitochondrial fraction of
rat kidneys has been reported after 30 mm of ischemia and
rising to levels fourfold over control values at 4 hr. The
accumulation of linolejc and arachidonic acids to levels seven
times control suggests an increase in phospholipase A2 activity
[78]. It is possible that the mechanism of injury by ischemia or
nephrotoxins may relate in part to the formation of free radicals
leading to lipid peroxidation of plasma membranes in the kidney
[79]. In gentamicin-induced acute renal failure, an increase in
both acidic phospholipids and phosphotidylinositol has been
reported [80, 81].
Production of hormones
In ischemic models of renal injury produced by vascular
clamping renin secretion is increased by 15 mm and remains
elevated at 24 hr [82, 83]. In mercury chloride-induced renal
failure there is also an increase in renin and angiotensin II
during the induction phase of injury. Later, secretion rates
return to normal [84].
Increased levels of renin and angiotensin may produce vaso-
constriction, leading to further ischemia and more severe renal
injury. Earlier studies demonstrated a protective effect of
chronic salt loading in the development of acute renal failure in
several experimental models. Since salt loading is known to
suppress the activity of the renin-angiotensin system, it was
proposed that the protection afforded by salt loading in acute
renal failure was due to suppression of intrarenal renin activity
[85]. Despite the above observations, most recent data suggest
that the role of the renin-angiotensin system in acute renal
failure is, at best, minor. Intrarenal renin is apparently not a
mediator of the vasoconstriction observed in experimental
models of acute renal failure [85].
Role of prostanoids in animal models of acute renal failure
Table 2 presents a summary of the effects of acute renal
failure on prostaglandin synthesis in different animal models
and summarizes the inhibitive effect of prostaglandin synthesis
on the course of the renal failure and whether or not the
exogenous infusion of prostaglandins may be protective. Al-
though in the basal state prostaglandins appear to exert little or
no influence on renal hemodynamics [87—89] these fatty acids,
however, play a major role in preserving the normalcy of renal
hemodynamics in anesthetized animals [89—91] and in condi-
tions where renal hemodynamics are compromised such as
decreases in effective plasma volume due to hemorrhage or
anesthesia [92—95], in liver disease [96—98], and in congestive
heart failure [99]. It should be remembered that vasodilatory
prostaglandins tend to antagonize the vasoconstrictive re-
sponses to angiotensin II and other pressor hormones
[100—104]. The protective effect of prostaglandins can, of
course, be abolished by pretreatment with cyclooxygenase
inhibitors.
Chronic renal disease
Most of the published data regarding metabolic alterations of
the nephron in chronic renal disease have utilized the remnant
kidney model in experimental animals. In this model a decrease
in renal mass is accomplished by either partial ablation of renal
parenchyma or ligation of renal arteries to one kidney and
contralateral nephrectomy. Metabolic studies examining ex-
traction of substrate across the renal vascular bed have also
been conducted in humans with spontaneous chronic renal
failure.
Energy production and substrate uptake
Studies have reported decreased renal uptake of phenylala-
nine, glutamine, proline, and citrulline, and decreased release
of ornithine, taurine, serine, threonine, alanine, arginine,
thyrosine, and lysine in humans with chronic renal failure [105].
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In the isolated perfused kidney obtained from rats with a
remnant kidney, amino acid uptake was less than normal 106].
Also, remnant kidneys from rats perfused in vitro tended to
excrete greater amounts of amino acids than normal kidneys
[107]. A decrease in renal mass results in increased ammonia
production per nephron, However, total ammonium production
by the remnant kidney does not equal total ammonium produc-
tion by the normal kidney [1081. In humans with chronic renal
failure [109] there is negligible glutamine extraction which does
not account for total ammonia production, which is reduced
[105]. In humans with metabolic acidosis induced by ammo-
nium chloride administration, ammonia production and excre-
tion increased significantly but the renal extraction of glutamine
did not increase, suggesting that other amino acids were used as
precursors for ammonia production. The renal extraction of
glycine and ornithine correlated with the degree of acidosis
[1101.
Changes in enzyme activity. After contralateral nephrectomy
an increase in the activity of phosphate-dependent glutaminase
in the remnant kidney has been reported [108]. There is also an
increase in glutamine dehydrogenase activity and ammonia
production. However, in rats fed a low protein diet prior to
contralateral nephrectomy, there is no increase in ammonia
production in the remnant kidney despite an increase in activity
of phosphate-dependent glutaminase. The activity of glutamic
dehydrogenase did not increase after contralateral nephrectomy
in the remnant kidney of rats fed a low-protein diet. This
decreased ammonia production and lack of adaptation of
glutamine dehydrogenase after contralateral nephrectomy was
not due to a diminished hydrogen load secondary to decreased
protein intake since administration of ammonium chloride to
equalize the total acid intake in low-protein fed rats to that seen
in high-protein fed rats did not increase the activity of glutamic
dehydrogenase.
The activity of Na-K ATPase increases in the outer medulla
and cortex of the rat remnant kidney with potassium loading
[1111. It was shown subsequently that potassium loading in-
creased Na-K ATPase in normal mouse kidney cortical collect-
ing tubule and medullary collecting duct [1121. A proportional
decrease in potassium intake prevents the increase in Na-K
ATPase that occurs in the outer medulla and cortex of the
remnant kidney after contralateral nephrectomy, These data
suggest that the increased activity of Na-K ATPase in the
remnant kidney is mediated by the need to excrete a greater
amount of potassium per nephron, However, other data indi-
cate that mild potassium loading resulted in a twofold increase
in potassium excretion by the remnant kidney without signifi-
cant increase in Na-K ATPase in cortical collecting tubules of
rabbits [113].
Hormonal production and response to hormones. It has been
shown that the hydro-osmotic response to vasopressin of cor-
tical collecting tubules obtained from the remnant kidney of
rabbits is reduced as compared to the response obtained in
cortical collecting ducts obtained from normal kidneys
[114—116]. The activation of adenylate cyclase by vasopressin
was also reduced. Administration of theophylline or 8-bromo-
cyclic AMP did not restore the hydro-osmotic response to
normal. These data would suggest that there is a defect both
pre- and post-generation of cyclic AMP in the hydro-osmotic
response of the cortical collecting tubule to vasopressin. These
data are similar to those reported by Campbell, Klahr, and
Bello-Reuss [34] in cortical collecting tubules obtained from
obstructed rabbit kidneys.
Regarding the response to PTH and its effect on phosphate
excretion conflicting results have been reported. A decreased
sensitivity to PTH of the remnant kidney, as measured by the
phosphaturic response, has been reported [117]. However,
other investigators have reported decreased or increased sen-
sitivity to PTH dependent on prior dietary phosphate intake
[1181. An increased sensitivity to PTH has also been reported in
parathyroidectomized rats with a remnant kidney. These results
would exclude the possibility that increased levels of circulating
PTH in vivo may be responsible for the decreased sensitivity to
PTH in vitro [119]. Also, phosphorus reabsorption in the
proximal tubule and the loop of Henle was low and decreased
further after PTH infusion in thyroparathyroidectomized dogs
with a remnant kidney [120].
Lipid metabolism
An increase in the synthetic rate of phosphorylcholine and a
decrease in the synthesis of betaine has been observed in the rat
3 and 8 weeks after the creation of a remnant kidney model. The
normal synthetic ratio of 1:2 was reversed. These differences
may be related to changes in the synthesis of plasma mem-
branes [121]. It has been noticed that after unilateral nephrec-
tomy the incorporation of choline into the phospholipid pool
precedes any changes in protein, uridine, and thymidine metab-
olism [1221. It has been shown also that this increase in choline
incorporation does not depend on an increased sodium trans-
port or increased single nephron GFR [123].
An increased excretion of prostaglandins has been reported
in humans with chronic renal disease [124] and also in animals
with reduced renal mass [125]. In rabbits with a remnant
kidney, Kirschenbaum and Serros [1251 demonstrated that the
administration of inhibitors of cyclo-oxygenase decreased
GFR, whereas the same dose of inhibitors of cyclo-oxygenase
had no effect on GFR in normal animals, suggesting that
prostaglandins play a key role in the maintenance of GFR in the
remnant kidney model.
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